| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/2006 | CA2572643A1 Novel carbamylated epo and method for its production |
| 01/12/2006 | CA2572547A1 Use of the receptor gpr86 |
| 01/12/2006 | CA2572225A1 Osk1 derivatives |
| 01/12/2006 | CA2572129A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | CA2572098A1 B7-dc binding antibody |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/12/2006 | CA2571287A1 Improved corn fractionation method |
| 01/12/2006 | CA2570566A1 Production of tissue factor in plants |
| 01/12/2006 | CA2569983A1 Recombinant rsv strains with altered g protein |
| 01/12/2006 | CA2569916A1 Functional screening assay |
| 01/12/2006 | CA2569795A1 Process for the purification of il-18 binding protein |
| 01/11/2006 | EP1614753A2 Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products |
| 01/11/2006 | EP1614752A2 Novel human 7TM proteins and polynucleotides encoding the same |
| 01/11/2006 | EP1614750A1 Novel functional peptide nucleic acid and process for producing the same |
| 01/11/2006 | EP1614697A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2006 | EP1614695A1 Polypeptide |
| 01/11/2006 | EP1614692A2 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/11/2006 | EP1614691A1 Antibacterial peptide |
| 01/11/2006 | EP1614690A1 Peptide fragment of lyve-1 and antibody against the same |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1614425A2 Leukotriene receptor antagonist |
| 01/11/2006 | EP1614424A1 Process for producing albumin preparation |
| 01/11/2006 | EP1614423A2 Attenuated pestiviruses |
| 01/11/2006 | EP1613964A2 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses |
| 01/11/2006 | EP1613958A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/11/2006 | EP1613796A2 Concentrated aqueous silk fibroin solution and use thereof |
| 01/11/2006 | EP1613761A2 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 01/11/2006 | EP1613757A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/11/2006 | EP1613752A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 01/11/2006 | EP1613751A1 Method for the construction of randomized gene sequence libraries in cells |
| 01/11/2006 | EP1613750A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 01/11/2006 | EP1613737A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/11/2006 | EP1613731A2 Modified adenoviral e1a constructs and methods of use thereof |
| 01/11/2006 | EP1613661A2 Peptabody for cancer treatment |
| 01/11/2006 | EP1613653A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2006 | EP1613652A2 A novel method of modulating bone-related activity |
| 01/11/2006 | EP1613651A2 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 01/11/2006 | EP1613650A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/11/2006 | EP1613649A2 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders |
| 01/11/2006 | EP1613648A1 Purification of peptides from colostrum |
| 01/11/2006 | EP1613647A2 Use of hcv proteins |
| 01/11/2006 | EP1613645A1 Analytical method and kit thereof |
| 01/11/2006 | EP1613644A1 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 01/11/2006 | EP1613643A2 Lupus antibodies for passive immunotherapy of hiv/aids |
| 01/11/2006 | EP1613642A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 01/11/2006 | EP1613572A2 Gpr54 receptor agonist and antagonist useful for the treatmentt of gonadotropin related diseases |
| 01/11/2006 | EP1613369A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 01/11/2006 | EP1613345A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 01/11/2006 | EP1613343A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 01/11/2006 | EP1613274A2 Conjugates comprising human il-18 and substitution mutants thereof |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613271A2 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1613267A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 01/11/2006 | EP1613262A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 01/11/2006 | EP1613146A2 Plants having modified growth characteristics and method for making the same |
| 01/11/2006 | EP1578452A4 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 01/11/2006 | EP1556084A4 Methods of regulating body weight |
| 01/11/2006 | EP1527090B1 Method of binding a compound to a surface |
| 01/11/2006 | EP1451581A4 Toll-like receptor 3 signaling agonists and antagonists |
| 01/11/2006 | EP1436761A4 Nanomachine compositions and methods of use |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1407033B1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 01/11/2006 | EP1392830B1 Interleukin-18 mutants, their production and use |
| 01/11/2006 | EP1252186B1 Use of neuregulin-beta as an indicator and/or target |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1179186B1 Method for identifying modulators of interacting proteins |
| 01/11/2006 | EP1165610B1 Peptide useful in treating multiple sclerosis and a pharmaceutical composition comprising the same |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP1135684B1 IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES |
| 01/11/2006 | EP1129198B1 Polypeptide compositions toxic to diabrotica insects, obtained from bacillus thuringiensis; cryet70, and methods of use |
| 01/11/2006 | EP1127143B1 Dna comprising rice anther-specific gene and transgenic plant transformed therewith |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1063294B1 Dnas or genes participating in parkinson's disease |
| 01/11/2006 | EP1029056B1 Plant-optimized genes encoding pesticidal toxins |
| 01/11/2006 | EP1012230B1 Renibacterium salmoninarum vaccine |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP0989805B1 Nucleic acid sequences for atp-binding cassette transporter |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | EP0797672B1 Use of a sec-dependent secretion system for secreting proteins that are usually secreted by a sec-independent secretion system |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0776972B1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 01/11/2006 | EP0771352B1 Nontypable haemophilus influenzae lkp tip adhesin protein and nucleic acid |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | EP0764210B1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 01/11/2006 | EP0745130B1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |
| 01/11/2006 | EP0741746B1 Analogs of thymosin alpha 1 |
| 01/11/2006 | EP0731636B1 Cdn apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720452A Method for screening modulators of mitochondrial fuctionning and new modulators obtained |
| 01/11/2006 | CN1720442A CIZI replication protein |
| 01/11/2006 | CN1720336A Use of A33 antigens and JAM-IT |
| 01/11/2006 | CN1720329A New expression system from rhodococcus |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720263A Trimeric binding proteins for trimeric cytokines |
| 01/11/2006 | CN1720262A Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 01/11/2006 | CN1720261A 疫苗 Vaccine |
| 01/11/2006 | CN1720066A Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 01/11/2006 | CN1720060A Human papillomavirus polypeptides and immunogenic compositions |